Champions Oncology Inc expected to post a loss of 20 cents a share - Earnings Preview

Champions Oncology

14/07/2025 12:07

Champions Oncology Inc CSBR.OQ CSBR.O is expected to show a fall in quarterly revenue when it reports  results on July 16 (estimated) for the period ending April 30 2025

The Hackensack New Jersey-based  company is expected to report a 14.2% decrease in revenue to $12.013 million from $14 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Champions Oncology Inc is for a loss of 20 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Champions Oncology Inc is $12.00, about 32.5% above its last closing price of $8.10

This summary was machine generated July 14 at 11:07 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)